Showing Results : 1-1 of 1
Sort By :
  • Results in Chemistry: 2021, vol: 3, issue:
  • 1)- Yustina Hartini, Bakti Saputra, Bryan Wahono, Zerlinda Auw, Friska Indayani, Lintang Adelya, Gabriel Namba, Maywan Hariono. Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus. Results in chemistry. 2021, 3: 100087
    Cited : 12
    Read More
  • 2)- Ivonne Buitrón-González, Giovanny Aguilera-Durán, Antonio Romo-Mancillas. In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex. Results in chemistry. 2021, 3: 100094
    Cited : 6
    Read More
  • 3)- Pandu Hariyono, Christine Patramurti, Damiana S Candrasari, Maywan Hariono. An integrated virtual screening of compounds from leaves against multiple protein targets of SARS-Coronavirus-2. Results in chemistry. 2021, 3: 100113
    Cited : 9
    Read More
  • 4)- Insa Seck, Filomain Nguemo. Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus. Results in chemistry. 2021, 3: 100132
    Cited : 27
    Read More
  • 5)- Abhijeet Mohanty, Adarsh P Fatrekar, Saravanan Krishnan, Amit A Vernekar. A concise discussion on the potential spectral tools for the rapid COVID-19 detection. Results in chemistry. 2021, 3: 100138
    Cited : 3
    Read More
  • 6)- Anil Pawar, Amit Pal, Kalyan Goswami, Rosanna Squitti, Mauro Rongiolettie. Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis. Results in chemistry. 2021, 3: 100148
    Cited : 11
    Read More
  • 7)- Maywan Hariono, Pandu Hariyono, Rini Dwiastuti, Wahyuning Setyani, Muhammad Yusuf, Nurul Salin, Habibah Wahab. Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies. Results in chemistry. 2021, 3: 100195
    Cited : 13
    Read More
 
 


Journal List
Links
Content Links
About Us

0